SCHEMBL2312925

SCHEMBL2312925

[O-][S+]1c2ccccc2Cc2c(CCO)cc(CCO)cc21

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312884 0.83 PNMT (0.34)
SCHEMBL2308580 0.81 TDP1 (0.33) TDP1
SCHEMBL2309979 0.80 TDP1 (0.36) TDP1
SCHEMBL2310260 0.80 KDM4E (0.32)
SCHEMBL2307739 0.77 KDM4E (0.32)
SCHEMBL2307403 0.77 TDP1 (0.36) TDP1
SCHEMBL2311185 0.77
SCHEMBL2308128 0.77
SCHEMBL2309520 0.76
SCHEMBL3484129 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed